Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, LA 70112, USA.
J Pharmacol Exp Ther. 2010 Apr;333(1):174-83. doi: 10.1124/jpet.109.161489. Epub 2010 Jan 21.
ADP-ribosylation factors (ARFs) regulate vesicular traffic through recruiting coat proteins. However, their functions in the anterograde transport of nascent G protein-coupled receptors (GPCRs) from the endoplasmic reticulum to the plasma membrane remain poorly explored. Here we show that treatment with brefeldin A, an inhibitor of guanine nucleotide exchange on ARFs, markedly attenuated the cell surface numbers of alpha(2B)-adrenergic receptor (AR), beta(2)-AR, angiotensin II type 1 receptor, and chemokine (CXC motif) receptor 4. Functional inhibition of individual ARF GTPases by transient expression of the GDP-bound, GTP-bound, and guanine nucleotide-deficient mutants showed that the five human ARFs differentially modulated receptor cell surface expression and that the ARF1 mutants produced the most profound inhibitory effect. Furthermore, expression of the ARF1 GTPase-activating protein (GAP) ARFGAP1 significantly blocked receptor transport. Interestingly, the GDP- and GTP-bound ARF1 mutants arrested the receptors in distinct intracellular compartments. Consistent with the reduced receptor cell surface expression, extracellular signal-regulated kinase 1 and 2 activation by receptor agonists was significantly attenuated by the GDP-bound mutant ARF1T31N. Moreover, coimmunoprecipitation showed that alpha(2B)-AR associated with ARF1 and glutathione transferase pull-down assay indicated that the alpha(2B)-AR C terminus directly interacted with ARF1. These data show that ARF1 GTPase is involved in the regulation of cell surface expression of GPCRs at multiple transport steps.
ADP-核糖基化因子 (ARFs) 通过招募衣壳蛋白来调节囊泡运输。然而,它们在从内质网到质膜的新生 G 蛋白偶联受体 (GPCR) 的顺行运输中的功能仍未得到充分探索。在这里,我们发现用布雷非德菌素 A(一种 ARF 上鸟嘌呤核苷酸交换的抑制剂)处理,明显减弱了α(2B)-肾上腺素能受体 (AR)、β(2)-AR、血管紧张素 II 型 1 受体和趋化因子 (CXC 基序) 受体 4 的细胞表面数量。通过瞬时表达 GDP 结合、GTP 结合和鸟嘌呤核苷酸缺乏突变体的功能抑制单个 ARF GTPase 表明,五种人类 ARF 不同程度地调节受体的细胞表面表达,并且 ARF1 突变体产生最深远的抑制作用。此外,ARF1 GTP 酶激活蛋白 (ARFGAP1) 的表达显著阻断了受体的转运。有趣的是,GDP 和 GTP 结合的 ARF1 突变体将受体截留在不同的细胞内隔室中。与受体细胞表面表达减少一致,激动剂诱导的细胞外信号调节激酶 1 和 2 的激活被 GDP 结合的 ARF1T31N 突变体显著减弱。此外,共免疫沉淀表明α(2B)-AR 与 ARF1 相关,谷胱甘肽转移酶下拉测定表明α(2B)-AR C 末端直接与 ARF1 相互作用。这些数据表明 ARF1 GTPase 参与调节 GPCR 在多个运输步骤中的细胞表面表达。